drugset / Trial / NCT02908490

Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis?

NCT02908490

Phase 2 Terminated 25 enrolled Kimberly Liang
RandomizedCrossoverDouble-blindPrevention

Summary

The purpose of this study is to determine whether sildenafil improves parameters of vascular function and blood markers involved in development of heart disease in patients with rheumatoid arthritis.

Timeline

Start
2017-04-01
Primary completion
2020-06-04
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 50 mg Oral